START FREE TRIAL
Home Healthcare Chemed Corporation

Chemed Corporation

$19.00

SKU: CHE Category:

Description

Chemed’s 44.7% VITAS Profit Surge — Can Roto-Rooter Catch Up?

 

Chemed Corporation reported financial results for the third quarter of 2026 showing continued growth in both of its primary businesses, VITAS Healthcare and Roto-Rooter. Consolidated revenue increased 10.6% year over year, driven by 12.2% revenue growth at VITAS and 7.5% growth at Roto-Rooter. Adjusted diluted earnings per share rose 28.1%, aided by strong operational performance and cost management. VITAS Healthcare, the hospice care segment, delivered robust results with a 44.7% increase in adjusted net income, attributable to a 9.4% rise in days of care and improved Medicare reimbursement rates. Admissions increased 7.2%, supporting revenue growth. VITAS maintained a Medicare cap year-end cushion exceeding $34 million for its Florida combined program and managed to stay below projected Medicare cap limits in non-Florida markets, indicating effective risk management of reimbursement constraints. Operational efficiencies were supported by enhanced electronic staffing tools and a disciplined approach to labor and administrative costs, which declined $2.